Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. DUOBRII drug price trends. Drug patent litigation for DUOBRII. …
Annual Drug Patent Expirations for RISVAN Risvan is a drug marketed by Labs Farms Rovi Sa and is included in one NDA. The generic ingredient in RISVAN is risperidone. Additional details are available on the risperidone profile page. For more informatio…
Annual Drug Patent Expirations for INGREZZA+SPRINKLE Ingrezza Sprinkle is a drug marketed by Neurocrine and is included in one NDA. […]
Source
New patent for Neurocrine drug INGREZZA SPRINKLE Read Post »
Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one […]
Source
Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. […]
Source
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are eleven patents protecting…
Source
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers. There are six patents protecting…
Source
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers. There are seventy patents…
Source